Target intelligence / Profile preview

Drug transporter protein

Molecular classification
Transporter, ABC transporter (ATP-binding cassette), P-type ATPase, Solute carrier family (SLC)
01

Overview

Drug transporter proteins are specialized membrane-spanning proteins that facilitate the movement of ions, peptides, small molecules—including many pharmaceutical agents—lipids, and macromolecules across biological membranes. They play critical roles in pharmacokinetics by regulating the absorption, distribution, metabolism, and excretion of drugs. Major classes include ATP-binding cassette (ABC) transporters—which often mediate multidrug resistance in cancer by actively exporting chemotherapeutic agents out of cells—P-type ATPases that pump cations using energy from ATP hydrolysis, and solute carrier (SLC) families involved in secondary active transport or facilitated diffusion. The broad term "drug transporter protein" is not a precise molecular target but refers to a large group comprising many distinct proteins with diverse substrate specificities and physiological roles[1][3][4]. > Note: The entry "Drug transporter protein" is too generic for structured data extraction about a single molecular entity. It encompasses numerous distinct proteins with different names/functions/families; therefore it should be flagged as incorrect for use as a canonical target name. For structured information on therapeutic targeting or pharmacology research purposes, it is necessary to specify an exact member such as "P-glycoprotein" (ABCB1), "Organic anion transporting polypeptide 1B1" (SLCO1B1), etc.[6]

Other names
Membrane transporterTransporter proteinDrug transporterMembrane transport/carrier protein
02

Biological functions

Movement of drugs and small molecules across biological membranesRegulation of drug absorption, distribution, and excretionMaintenance of cellular homeostasis
03

Disease associations

Cancer (notably in multidrug resistance)Neurological disorders (e.g., depression, Parkinson’s disease)EpilepsyOther diseases involving altered drug disposition or toxicity

Beyond the preview

Go deeper on Drug transporter protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Drug transporter protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call